Fuchs, Claudia D.

Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology

Fuchs, C. D., & Trauner, M. (2022) · Nature Reviews Gastroenterology & Hepatology

Drug Transport and Resistance MechanismsCholesterol and Lipid Metabolism

Cited by 490

New therapeutic concepts in bile acid transport and signaling for management of cholestasis

Trauner, M., Fuchs, C. D., Halilbasic, E., & Paumgartner, G. (2017) · Hepatology

Drug Transport and Resistance MechanismsLiver Diseases and Immunity

Cited by 227

Novel therapeutic targets for cholestatic and fatty liver disease

Trauner, M., & Fuchs, C. D. (2022) · Gut

Liver Disease Diagnosis and TreatmentDrug Transport and Resistance Mechanisms

Cited by 204

Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis

Baghdasaryan, A., Fuchs, C. D., Österreicher, C. H., Lemberger, U. J., Halilbasic, E., Påhlman, I., Graffner, H., Krones, E., Fickert, P., Wahlström, A., et al. (2016) · Journal of Hepatology

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 187

Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis

Reich, M., Spomer, L., Klindt, C., Fuchs, K., Stindt, J., Deutschmann, K., Höhne, J., Liaskou, E., Hov, J. R., Karlsen, T. H., et al. (2021) · Journal of Hepatology

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 121

Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease

Fuchs, C., Traussnigg, S., & Trauner, M. (2016) · Seminars in Liver Disease

Liver Disease Diagnosis and TreatmentPeroxisome Proliferator-Activated Receptors

Cited by 100

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2−/− mice by modulating composition, signalling and excretion of faecal bile acids

Fuchs, C. D., Paumgartner, G., Mlitz, V., Kunczer, V., Halilbasic, E., Leditznig, N., Wahlström, A., Ståhlman, M., Thüringer, A., Kashofer, K., et al. (2018) · Gut

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 76

Na + -taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice

Slijepcevic, D., Roscam Abbing, R. L. P., Fuchs, C. D., Haazen, L. C. M., Beuers, U., Trauner, M., Oude Elferink, R. P. J., & van de Graaf, S. F. J. (2018) · Hepatology

Drug Transport and Resistance MechanismsLiver physiology and pathology

Cited by 73

24-Norursodeoxycholic acid reshapes immunometabolism in CD8(+) T cells and alleviates hepatic inflammation

Zhu, C., Boucheron, N., Müller, A. C., Májek, P., Claudel, T., Halilbasic, E., Baazim, H., Lercher, A., Viczenczova, C., Hainberger, D., et al. (2021) · Journal of Hepatology

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 65

Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease

Blokker, B. A., Maijo, M., Echeandia, M., Galduroz, M., Patterson, A. M., Ten, A., Philo, M., Schungel, R., Gutierrez‐de Juan, V., Halilbasic, E., et al. (2019) · Hepatology

Sirtuins and Resveratrol in MedicineLiver physiology and pathology

Cited by 46

Liver Capsule: FXR agonists against liver disease

Fuchs, C. D., Schwabl, P., Reiberger, T., & Trauner, M. (2016) · Hepatology

Drug Transport and Resistance MechanismsLiver Disease Diagnosis and Treatment

Cited by 20